Logo image of CGNX

COGNEX CORP (CGNX) Stock Fundamental Analysis

USA - NASDAQ:CGNX - US1924221039 - Common Stock

39.27 USD
-0.27 (-0.68%)
Last: 11/7/2025, 8:00:00 PM
39.27 USD
0 (0%)
After Hours: 11/7/2025, 8:00:00 PM
Fundamental Rating

7

Overall CGNX gets a fundamental rating of 7 out of 10. We evaluated CGNX against 124 industry peers in the Electronic Equipment, Instruments & Components industry. CGNX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CGNX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CGNX had positive earnings in the past year.
In the past year CGNX had a positive cash flow from operations.
Each year in the past 5 years CGNX has been profitable.
In the past 5 years CGNX always reported a positive cash flow from operatings.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of CGNX (5.50%) is better than 75.81% of its industry peers.
CGNX's Return On Equity of 7.39% is fine compared to the rest of the industry. CGNX outperforms 65.32% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.09%, CGNX is in the better half of the industry, outperforming 70.16% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CGNX is in line with the industry average of 9.51%.
Industry RankSector Rank
ROA 5.5%
ROE 7.39%
ROIC 7.09%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CGNX (11.33%) is better than 87.10% of its industry peers.
In the last couple of years the Profit Margin of CGNX has declined.
The Operating Margin of CGNX (16.27%) is better than 90.32% of its industry peers.
CGNX's Operating Margin has declined in the last couple of years.
CGNX's Gross Margin of 67.65% is amongst the best of the industry. CGNX outperforms 97.58% of its industry peers.
CGNX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.27%
PM (TTM) 11.33%
GM 67.65%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

CGNX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CGNX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CGNX has been reduced compared to 5 years ago.
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 9.10 indicates that CGNX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.10, CGNX belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.1
ROIC/WACC0.77
WACC9.17%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 3.96 indicates that CGNX has no problem at all paying its short term obligations.
CGNX has a better Current ratio (3.96) than 73.39% of its industry peers.
CGNX has a Quick Ratio of 3.11. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.11, CGNX is in the better half of the industry, outperforming 76.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.96
Quick Ratio 3.11
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.62% over the past year.
CGNX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.03% yearly.
Looking at the last year, CGNX shows a quite strong growth in Revenue. The Revenue has grown by 10.23% in the last year.
CGNX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.74% yearly.
EPS 1Y (TTM)44.62%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%65%
Revenue 1Y (TTM)10.23%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%17.96%

3.2 Future

CGNX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.65% yearly.
The Revenue is expected to grow by 9.52% on average over the next years. This is quite good.
EPS Next Y31.11%
EPS Next 2Y25.7%
EPS Next 3Y23.02%
EPS Next 5Y29.65%
Revenue Next Year7.81%
Revenue Next 2Y7.89%
Revenue Next 3Y8.29%
Revenue Next 5Y9.52%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 41.78, which means the current valuation is very expensive for CGNX.
The rest of the industry has a similar Price/Earnings ratio as CGNX.
CGNX is valuated expensively when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 33.59, the valuation of CGNX can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CGNX is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 32.68. CGNX is around the same levels.
Industry RankSector Rank
PE 41.78
Fwd PE 33.59
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CGNX's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CGNX indicates a somewhat cheap valuation: CGNX is cheaper than 71.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.84
EV/EBITDA 32.98
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CGNX may justify a higher PE ratio.
CGNX's earnings are expected to grow with 23.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.34
PEG (5Y)N/A
EPS Next 2Y25.7%
EPS Next 3Y23.02%

5

5. Dividend

5.1 Amount

CGNX has a yearly dividend return of 0.86%, which is pretty low.
Compared to an average industry Dividend Yield of 2.07, CGNX pays a better dividend. On top of this CGNX pays more dividend than 83.87% of the companies listed in the same industry.
With a Dividend Yield of 0.86, CGNX pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.86%

5.2 History

The dividend of CGNX is nicely growing with an annual growth rate of 8.39%!
CGNX has been paying a dividend for at least 10 years, so it has a reliable track record.
CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)8.39%
Div Incr Years3
Div Non Decr Years3
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

49.16% of the earnings are spent on dividend by CGNX. This is a bit on the high side, but may be sustainable.
The dividend of CGNX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y25.7%
EPS Next 3Y23.02%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

COGNEX CORP

NASDAQ:CGNX (11/7/2025, 8:00:00 PM)

After market: 39.27 0 (0%)

39.27

-0.27 (-0.68%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners101.95%
Inst Owner Change-1.33%
Ins Owners0.27%
Ins Owner Change0.04%
Market Cap6.59B
Revenue(TTM)971.71M
Net Income(TTM)110.12M
Analysts75.86
Price Target48.6 (23.76%)
Short Float %2.68%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield 0.86%
Yearly Dividend0.31
Dividend Growth(5Y)8.39%
DP49.16%
Div Incr Years3
Div Non Decr Years3
Ex-Date11-13 2025-11-13 (0.085)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.79%
Min EPS beat(2)3.71%
Max EPS beat(2)11.87%
EPS beat(4)4
Avg EPS beat(4)15.13%
Min EPS beat(4)3.71%
Max EPS beat(4)26.05%
EPS beat(8)8
Avg EPS beat(8)16.02%
EPS beat(12)11
Avg EPS beat(12)15.02%
EPS beat(16)14
Avg EPS beat(16)16.54%
Revenue beat(2)1
Avg Revenue beat(2)1.36%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)3.51%
Revenue beat(4)2
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)3.51%
Revenue beat(8)4
Avg Revenue beat(8)0.74%
Revenue beat(12)6
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)0.94%
PT rev (1m)2.8%
PT rev (3m)26.71%
EPS NQ rev (1m)1.71%
EPS NQ rev (3m)19.63%
EPS NY rev (1m)0.56%
EPS NY rev (3m)7.98%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)5.21%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.08%
Valuation
Industry RankSector Rank
PE 41.78
Fwd PE 33.59
P/S 6.79
P/FCF 30.84
P/OCF 29.7
P/B 4.43
P/tB 6.52
EV/EBITDA 32.98
EPS(TTM)0.94
EY2.39%
EPS(NY)1.17
Fwd EY2.98%
FCF(TTM)1.27
FCFY3.24%
OCF(TTM)1.32
OCFY3.37%
SpS5.79
BVpS8.87
TBVpS6.02
PEG (NY)1.34
PEG (5Y)N/A
Graham Number13.7
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 7.39%
ROCE 8.62%
ROIC 7.09%
ROICexc 8.48%
ROICexgc 12.33%
OM 16.27%
PM (TTM) 11.33%
GM 67.65%
FCFM 22%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
ROICexc(3y)9.56%
ROICexc(5y)11.82%
ROICexgc(3y)12.73%
ROICexgc(5y)15.09%
ROCE(3y)9.35%
ROCE(5y)11.55%
ROICexgc growth 3Y-25.69%
ROICexgc growth 5Y-4.75%
ROICexc growth 3Y-29.85%
ROICexc growth 5Y-7.09%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 26.24%
Cap/Sales 0.85%
Interest Coverage 250
Cash Conversion 117.19%
Profit Quality 194.14%
Current Ratio 3.96
Quick Ratio 3.11
Altman-Z 9.1
F-Score8
WACC9.17%
ROIC/WACC0.77
Cap/Depr(3y)84%
Cap/Depr(5y)75.71%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.9%
Profit Quality(3y)103.13%
Profit Quality(5y)109.22%
High Growth Momentum
Growth
EPS 1Y (TTM)44.62%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%65%
EPS Next Y31.11%
EPS Next 2Y25.7%
EPS Next 3Y23.02%
EPS Next 5Y29.65%
Revenue 1Y (TTM)10.23%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%17.96%
Revenue Next Year7.81%
Revenue Next 2Y7.89%
Revenue Next 3Y8.29%
Revenue Next 5Y9.52%
EBIT growth 1Y67.86%
EBIT growth 3Y-28.52%
EBIT growth 5Y-4.2%
EBIT Next Year53.61%
EBIT Next 3Y31.29%
EBIT Next 5Y22.1%
FCF growth 1Y47.96%
FCF growth 3Y-23.43%
FCF growth 5Y-10.36%
OCF growth 1Y34.8%
OCF growth 3Y-22%
OCF growth 5Y-10.06%

COGNEX CORP / CGNX FAQ

What is the fundamental rating for CGNX stock?

ChartMill assigns a fundamental rating of 7 / 10 to CGNX.


What is the valuation status of COGNEX CORP (CGNX) stock?

ChartMill assigns a valuation rating of 4 / 10 to COGNEX CORP (CGNX). This can be considered as Fairly Valued.


What is the profitability of CGNX stock?

COGNEX CORP (CGNX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for COGNEX CORP?

The Earnings per Share (EPS) of COGNEX CORP (CGNX) is expected to grow by 31.11% in the next year.


Can you provide the dividend sustainability for CGNX stock?

The dividend rating of COGNEX CORP (CGNX) is 5 / 10 and the dividend payout ratio is 49.16%.